These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2392130)

  • 21. Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1987 Mar; 187(3):141-9. PubMed ID: 3821767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
    Moore MM; Applegate ML; Hozier JC
    Mutat Res; 1988 Feb; 207(2):77-82. PubMed ID: 2448615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-resolution cytogenetic characterization of the L5178Y TK+/- mouse lymphoma cell line.
    Sawyer JR; Moore MM; Hozier JC
    Mutat Res; 1989 Oct; 214(2):181-93. PubMed ID: 2797024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of large and small colony L5178Y tk-/- mouse lymphoma mutants by loss of heterozygosity (LOH) and by whole chromosome 11 painting: detection of recombination.
    Liechty MC; Scalzi JM; Sims KR; Crosby H; Spencer DL; Davis LM; Caspary WJ; Hozier JC
    Mutagenesis; 1998 Sep; 13(5):461-74. PubMed ID: 9800191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenicity and clastogenicity of proflavin in L5178Y/TK +/- -3.7.2.C cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1988 Feb; 204(2):323-8. PubMed ID: 3343981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of mutants at the APRT locus in the L-5178Y TK+/TK- mouse lymphoma cell line.
    Paeratakul U; Taylor MW
    Mutat Res; 1986 Mar; 160(1):61-9. PubMed ID: 3951457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methapyrilene is a genotoxic carcinogen: studies on methapyrilene and pyrilamine in the L5178Y/TK +/- mouse lymphoma assay.
    Turner NT; Woolley JL; Hozier JC; Sawyer JR; Clive D
    Mutat Res; 1987 Nov; 189(3):285-97. PubMed ID: 3670332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic distinction between the TK+ and TK- chromosomes in the L5178Y TK+/- 3.7.2C mouse-lymphoma cell line.
    Hozier J; Sawyer J; Clive D; Moore M
    Mutat Res; 1982 Dec; 105(6):451-6. PubMed ID: 7155165
    [No Abstract]   [Full Text] [Related]  

  • 29. The mouse lymphoma assay.
    Lloyd M; Kidd D
    Methods Mol Biol; 2012; 817():35-54. PubMed ID: 22147567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of the TK locus in L5178Y large and small colony mouse lymphoma cell mutants induced by hycanthone methanesulfonate.
    el-Tarras A; Dubins JS; Warner J; Hoffman C; Cobb RR
    Mutat Res; 1995 Nov; 332(1-2):89-95. PubMed ID: 7500995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micronucleus, chromosome aberration, and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells.
    Doerr CL; Harrington-Brock K; Moore MM
    Mutat Res; 1989 Mar; 222(3):191-203. PubMed ID: 2466200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of mutagenic effects of hyperbaric oxygen (HBO) in vitro. II. Induction of oxidative DNA damage and mutations in the mouse lymphoma assay.
    Rothfuss A; Merk O; Radermacher P; Speit G
    Mutat Res; 2000 Nov; 471(1-2):87-94. PubMed ID: 11080664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific gene mutations in L5178Y cells in culture.
    Clive D; McCuen R; Spector JF; Piper C; Mavournin KH
    Mutat Res; 1983 Jun; 115(2):225-51. PubMed ID: 6855786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bromate induces loss of heterozygosity in the thymidine kinase gene of L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.
    Harrington-Brock K; Collard DD; Chen T
    Mutat Res; 2003 May; 537(1):21-8. PubMed ID: 12742504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of the mouse thymidine kinase gene to the distal portion of chromosome 11.
    Hozier J; Scalzi J; Sawyer J; Carley N; Applegate M; Clive D; Moore MM
    Genomics; 1991 Jul; 10(3):827-30. PubMed ID: 1889822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a heteromorphic microsatellite within the thymidine kinase gene in L5178Y mouse lymphoma cells.
    Liechty MC; Crosby H; Murthy A; Davis LM; Caspary WJ; Hozier JC
    Mutat Res; 1996 Dec; 371(3-4):265-71. PubMed ID: 9008728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of microsatellite DNA polymorphisms on mouse chromosome 11 for in vitro analysis of thymidine kinase gene mutations.
    Liechty MC; Hassanpour Z; Hozier JC; Clive D
    Mutagenesis; 1994 Sep; 9(5):423-7. PubMed ID: 7837976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large mutagenic lesions are induced by photodynamic therapy in murine L5178Y lymphoblasts.
    Deahl JT; Oleinick NL; Evans HH
    Photochem Photobiol; 1993 Aug; 58(2):259-64. PubMed ID: 8415919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetic characterization of the L5178Y TK+/-3.7.2C mouse lymphoma cell line.
    Sawyer J; Moore MM; Clive D; Hozier J
    Mutat Res; 1985 Oct; 147(5):243-53. PubMed ID: 4047079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.
    Wang J; Heflich RH; Moore MM
    Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.